Emiten MERK

← Daftar Emiten

MERK

MERKDrug Manufacturers - Specialty & GenericHealthcare

Ringkasan Bisnis

PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally. The company operates through three segments: Biopharma, Consumer Health, and Others. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in research an, development, production, and distribution of pharmaceutical and biological prescription medicines to treat colorectal cancer, head and neck cancer, multiple sclerosis, infertility, growth hormone disorders, and diabetes, as well as thyroid disorders, such as hypothyroidism. In addition, it is involved in the office/property leasing and management activities. The company was formerly known as PT Merck Indonesia Tbk and changed its name to PT Merck Tbk in June 2002. The company was founded in 1970 and is headquartered in Jakarta Timur, Indonesia. PT Merck Tbk operates as a subsidiary of Merck Holding GmbH.

Web: https://www.merckgroup.com/id-idTelp: 62 21 2856 5600Jl. TB Simatupang No. 8, Jakarta Timur, 13760, Indonesia

Grafik Harga MERK

Riwayat Dividen

Cum DateDividendYield %
2020-08-101303.87%
2018-12-21256545.54%
2018-12-173.260.08%
2018-07-032606.33%
2017-04-252755.04%
2016-04-061002.47%
2015-11-181654.39%
2015-04-136500162.94%
2014-04-1562501264.24%
2013-04-1535702533.80%
2012-05-11827011603.61%
2011-05-094464-64553.19%
2010-09-173570-547240.63%
2010-04-281339-1501677.02%
2009-04-275350-15007520.74%
2008-05-0923004790078.47%
2007-05-21200049118932.26%
2006-05-171400247647621.66%
2005-05-0614004112229632.74%
2004-11-241400-260820662933.17%
2004-05-0714001488766829528.48%
2003-12-02800-3907003342563.69%
2003-06-061000612653268655370.25%
2003-01-10300-210406835281107.41%
2002-06-24400-449587339868683.13%

Alur Keuangan MERK

Total Revenue → Cost of Goods Sold: Rp629.36 MTotal Revenue → Gross Profit: Rp571.30 MGross Profit → Operating Expenses: Rp249.95 MGross Profit → Operating Income (EBIT): Rp321.36 MOperating Income (EBIT) → Interest Expense: Rp1.75 MOperating Income (EBIT) → Pre-Tax Income: Rp327.34 MPre-Tax Income → Taxes: Rp83.44 MPre-Tax Income → Net Income: Rp243.90 MNet Income → Dividends: Rp76.16 MNet Income → Retained Earnings: Rp931.27 MTotal Revenue: Rp1.20 TTotal RevenueCost of Goods Sold: Rp629.36 MCost of Goods SoldGross Profit: Rp571.30 MGross ProfitOperating Expenses: Rp249.95 MOperating ExpensesOperating Income (EBIT): Rp329.09 MOperating Income (EBIT)Interest Expense: Rp1.75 MInterest ExpensePre-Tax Income: Rp327.34 MPre-Tax IncomeTaxes: Rp83.44 MTaxesNet Income: Rp1.01 TNet IncomeDividends: Rp76.16 MDividendsRetained Earnings: Rp931.27 MRetained Earnings

Alur Arus Kas

Free Cash Flow → Cash Dividends Paid: Rp76.16 MFree Cash Flow → Change in Cash: Rp276.17 MFree Cash Flow: Rp352.33 MFree Cash FlowCash Dividends Paid: Rp76.16 MCash Dividends PaidChange in Cash: Rp276.17 MChange in Cash

Nilai dalam Rupiah. T = triliun, M = miliar. Arahkan kursor ke alur untuk melihat nilai.

mode: MARKET REGULER, build version: 5c32874, last update: Aug 09, 2026, 01:03:13 AM UTC, DYOR! Disclaimer ON!